WallStreetZenWallStreetZen

NASDAQ: IXHL
Incannex Healthcare Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IXHL

Based on 1 analyst offering 12 month price targets for Incannex Healthcare Inc

Min Forecast
$18.00+514.33%
Avg Forecast
$18.00+514.33%
Max Forecast
$18.00+514.33%

Should I buy or sell IXHL stock?

Based on 1 analyst offering ratings for Incannex Healthcare Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although IXHL's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates IXHL as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their IXHL stock forecasts and price targets.

IXHL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-06-08

1 of 1

Forecast return on equity

Is IXHL forecast to generate an efficient return?

Company
-42.6%
Industry
7.79%
Market
151.33%
IXHL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IXHL forecast to generate an efficient return on assets?

Company
-39.92%
Industry
16.72%
IXHL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IXHL earnings per share forecast

What is IXHL's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.58
Avg 2 year Forecast
-$2.68

IXHL revenue forecast

What is IXHL's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$31.5M
Avg 2 year Forecast
$0.0

IXHL vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
IXHL$2.93$18.00+514.33%Strong Buy
SCYX$3.73N/AN/A
RMTI$7.10$20.00+181.69%Buy
OPTH$4.69N/AN/A
TXMD$2.03N/AN/A
View Top Pharmaceutical Stocks

Incannex Healthcare Stock Forecast FAQ

Is Incannex Healthcare Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: IXHL) stock is to Strong Buy IXHL stock.

Out of 1 analyst, 1 (100%) are recommending IXHL as a Strong Buy, 0 (0%) are recommending IXHL as a Buy, 0 (0%) are recommending IXHL as a Hold, 0 (0%) are recommending IXHL as a Sell, and 0 (0%) are recommending IXHL as a Strong Sell.

If you're new to stock investing, here's how to buy Incannex Healthcare stock.

What is IXHL's earnings growth forecast for 2027-2028?

(NASDAQ: IXHL) Incannex Healthcare's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 18.89%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 69.59%.

Incannex Healthcare's earnings in 2026 is -$48,414,000.On average, 4 Wall Street analysts forecast IXHL's earnings for 2027 to be -$6,971,746, with the lowest IXHL earnings forecast at -$28,293,777, and the highest IXHL earnings forecast at $15,960,715.

In 2028, IXHL is forecast to generate -$32,047,058 in earnings, with the lowest earnings forecast at -$30,790,780 and the highest earnings forecast at -$32,989,865.

What is IXHL's revenue growth forecast for 2027-2028?

(NASDAQ: IXHL) Incannex Healthcare's forecast annual revenue growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 12.53%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.94%.

Incannex Healthcare's revenue in 2026 is $0.On average, 4 Wall Street analysts forecast IXHL's revenue for 2027 to be $376,835,593, with the lowest IXHL revenue forecast at $0, and the highest IXHL revenue forecast at $775,841,504.

In 2028, IXHL is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is IXHL's forecast return on assets (ROA) for 2027-2028?

(NASDAQ: IXHL) forecast ROA is -39.92%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 16.72%.

What is IXHL's Price Target?

According to 1 Wall Street analyst that have issued a 1 year IXHL price target, the average IXHL price target is $18.00, with the highest IXHL stock price forecast at $18.00 and the lowest IXHL stock price forecast at $18.00.

The Wall Street analyst predicted that Incannex Healthcare's share price could reach $18.00 by Jun 8, 2027. The average Incannex Healthcare stock price prediction forecasts a potential upside of 514.33% from the current IXHL share price of $2.93.

What is IXHL's Earnings Per Share (EPS) forecast for 2027-2028?

(NASDAQ: IXHL) Incannex Healthcare's current Earnings Per Share (EPS) is -$16.85. On average, analysts forecast that IXHL's EPS will be -$0.58 for 2027, with the lowest EPS forecast at -$2.36, and the highest EPS forecast at $1.33. In 2028, IXHL's EPS is forecast to hit -$2.68 (min: -$2.57, max: -$2.76).

What is IXHL's forecast return on equity (ROE) for 2027-2028?

(NASDAQ: IXHL) forecast ROE is -42.6%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.